NICE approves apixaban for treatment of DVT and pulmonary embolism

Patients can be given apixaban (Eliquis) on the NHS for the prevention and treatment of deep vein thrombosis and pulmonary embolism, NICE has ruled.

To treat deep vein thrombosis or pulmonary embolism, patients should be prescribed 10mg of apixaban twice daily for the first 7 days. | SCIENCE PHOTO LIBRARY
To treat deep vein thrombosis or pulmonary embolism, patients should be prescribed 10mg of apixaban twice daily for the first 7 days. | SCIENCE PHOTO LIBRARY

Apixaban directly inhibits factor Xa, suppressing thrombin formation and development of thrombi. Patients take an oral dose twice daily. 

Further information
NICE technology appraisal TA341

Apixaban is already recommended by NICE for prevention of stroke and systemic embolism in adults with nonvalvular atrial fibrillation and prevention of venous thromboembolism after total hip or knee replacement in adults.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New antibiotic guidance for leg ulcer infection

New antibiotic guidance for leg ulcer infection

NICE has issued guidance on antibiotic choices and...

New insertion site for Nexplanon following safety concerns

New insertion site for Nexplanon following safety concerns

The MHRA has amended its advice relating to the long-acting...

Antibiotic Treatments in Adults, Summary of Regimens

Antibiotic Treatments in Adults, Summary of Regimens

Dose regimens for common bacterial infections.

Beta blocker overdose warning for GPs

Beta blocker overdose warning for GPs

The toxicity of a commonly prescribed beta blocker...